The Government Accountability Office (GAO) released a study addressing ongoing drug shortages in the United States, which have been significantly exacerbated by the COVID-19 pandemic. Although the types of drugs in shortage remain consistent with pre-pandemic patterns, the report underscores how the pandemic deepened existing supply chain vulnerabilities, particularly in essential areas like oncology and injectable drugs. While the number… (Eisen, April 9, 2025) #Drug Pricing, #Food and Drug Administration